Tubeimoside

CAS : 102040-03-9

Ref. 3D-OT08921

Informations sur le produit

• Nom: Tubeimoside
• Synonymes: Lobatoside H3-[[2-O-[4-O-(4-Carboxy-3-hydroxy-3-methyl-1-oxobutyl-)-a-L-arabinopyranosyl]-b-D-glucopyranosyl]oxy]-2,23-dihydroxy-28 -(O-b-D-xylopyranosyl-(1-3)-O-6-deoxy-a-L-mannopyranosyl-(1-2)-a-L-arabinopyranosyl)ester, (1S,4S,7R,8S,9R,11S,13S,14S,18S,21R,22R,23S,24R,25R,27R,28S,29S,30R,32R,34R,35S,37S,38S,41R,42R,46S,53S,54R,56S,57R)-7,8,18,22,23,24,28,29,35,57-decahydroxy-30,54-bis(hydroxymethyl)-13,18,37,41,42,46,48,48,53,54-decamethyl-56-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}-3,5,10,12,15,26,31,33,55-nonaoxadecacyclo[39.9.3.2~11,14~.1~21,25~.1~34,38~.0~1,46~.0~4,9~.0~27,32~.0~37,42~.0~45,53~]heptapentacont-44-ene-2,16,20-trione (non-preferred name), Lobatoside H, Olean-12-en-28-oic acid, 3-[[2-O-[4-O-(4-carboxy-3-hydroxy-3-methyl-1-oxobutyl)-α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl]-β-<smallcap>D</smallcap>-glucopyranosyl]oxy]-2,23-dihydroxy-, 28-(O-β-<smallcap>D</smallcap>-xylopyranosyl-(1→3)-O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-α-<smallcap>L</span>-arabinopyranosyl) ester, intramol. ester, [2β,3β(S),4α]-, Olean-12-en-28-oic acid, 3-[[2-O-[4-O-[(3S)-4-carboxy-3-hydroxy-3-methyl-1-oxobutyl]-α-<span class="text-smallcaps">L</smallcap>-arabinopyranosyl]-β-<smallcap>D</smallcap>-glucopyranosyl]oxy]-2,23-dihydroxy-, 28-(O-β-<smallcap>D</smallcap>-xylopyranosyl-(1→3)-O-6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl-(1→2)-α-<smallcap>L</span>-arabinopyranosyl) ester, intramol. 4′′(3)→4′′(28)-ester, (2β,3β,4α)-, Tubeimoside 1, Tubeimoside I, Tubelmosidea, Tubemoside A, Tuberimoside 1, hydroxy-3-methyl-1-oxobutyl)-α-L-arabinopyra, nosyl]-β-D-glucopyranosyl]oxy]-2,23-dihydroxy-,28-(O-β-D-xylopyranosyl-(1→3)-O-6-deoxy-α-L-mannopyranosyl-(1→2)-α-L-arabinopyranosyl)ester, intramol. ester, [2β,3β(S),4α]-

Description

Tubeimoside is a natural compound that has been shown to have anti-cancer properties. Tubeimoside inhibits the mitochondrial membrane potential and induces apoptosis in HL-60 cells. It also synergizes with other anticancer drugs such as doxorubicin, cisplatin, and camptothecin. Tubeimoside has also been shown to inhibit the proliferation of human tumor cell lines and induce autophagy in k562 cells. This compound may be an effective chemotherapeutic agent for carcinomas.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 1,319.48 g/mol
• Formule: C₆₃H₉₈O₂₉
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder